Analysts Set Cabot Corporation (NYSE:CBT) Price Target at $73.75

Cabot Corporation (NYSE:CBT) has earned an average rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $73.75.

Several research analysts have commented on the company. UBS Group lifted their target price on Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Jefferies Financial Group restated a “buy” rating and set a $85.00 price objective on shares of Cabot in a research report on Wednesday, February 4th. JPMorgan Chase & Co. cut their price objective on Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research note on Friday, November 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cabot in a report on Monday, December 29th. Finally, Zacks Research upgraded shares of Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th.

Cabot Trading Down 1.5%

CBT opened at $67.95 on Monday. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.67 and a quick ratio of 1.09. Cabot has a fifty-two week low of $58.33 and a fifty-two week high of $84.89. The company’s 50 day moving average price is $73.04 and its two-hundred day moving average price is $70.73. The firm has a market capitalization of $3.55 billion, a price-to-earnings ratio of 11.90, a PEG ratio of 9.10 and a beta of 0.86.

Cabot (NYSE:CBT) last released its quarterly earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.13. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The firm had revenue of $849.00 million during the quarter, compared to the consensus estimate of $889.11 million. During the same quarter last year, the firm earned $1.76 earnings per share. The company’s revenue for the quarter was down 11.1% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, research analysts predict that Cabot will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Friday, February 27th were given a dividend of $0.45 per share. The ex-dividend date was Friday, February 27th. This represents a $1.80 annualized dividend and a dividend yield of 2.6%. Cabot’s dividend payout ratio is 31.52%.

Hedge Funds Weigh In On Cabot

Several hedge funds and other institutional investors have recently bought and sold shares of CBT. Ashton Thomas Private Wealth LLC boosted its position in shares of Cabot by 343.9% during the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 65,561 shares of the specialty chemicals company’s stock valued at $4,986,000 after purchasing an additional 50,792 shares in the last quarter. American Century Companies Inc. increased its holdings in Cabot by 11.1% in the second quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock worth $124,855,000 after purchasing an additional 166,460 shares in the last quarter. Paradiem LLC lifted its stake in Cabot by 65.5% in the third quarter. Paradiem LLC now owns 149,097 shares of the specialty chemicals company’s stock valued at $11,339,000 after buying an additional 59,030 shares during the period. Elo Mutual Pension Insurance Co bought a new position in shares of Cabot during the 3rd quarter worth approximately $1,040,000. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Cabot by 5.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,556,762 shares of the specialty chemicals company’s stock worth $118,392,000 after buying an additional 73,734 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.